CDx Strategies
Are you interested in developing a CDx for your preclinical drug program, but don't know where to begin? Forward Aspect assist pharma clients to understand the current landscape of molecular CDx development. We can evaluate and provide guidance in selecting potential partners/CROs. We can identify potential assays for your biomarker/target combination for use in clinical trials.